No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
An Intrinsic Calculation For Australian Clinical Labs Limited (ASX:ACL) Suggests It's 40% Undervalued
Australian Clinical Labs Ltd: AGM addresses
3 ASX All Ords Shares With 'Potential for Strong Future Performance'
Australian Clinical Labs Extends Chief Executive's Contract to August 2026
With 60% Institutional Ownership, Australian Clinical Labs Limited (ASX:ACL) Is a Favorite Amongst the Big Guns
Australian Clinical Labs Ltd: 2024 Annual Report
No Data